Search results for CDK1

Anti-CDK1 Antibody (R1K67), AntibodySystem, RHC20204

Cdk1 antibody (POH-1), Covalab, Ref 00113223

Purified anti-CDC2/CDK1 Phospho (Thr161) Antibody, CDC2/CDK1 Phopho Thr161, A23004F, BioLegend, 649151

This clone has cross reactivity with CDK2 phospho (Thr160) (verified), CDK3 phospho (Thr172) (verified), and CDK7 phospho (Thr170) (expected, not verified) due to the high homology/identity with CDK1 phospho (Thr161) site.

Purified anti-CDC2/CDK1 Phospho (Thr161) Antibody, CDC2/CDK1 Phopho Thr161, A23004F, BioLegend, 649152

This clone has cross reactivity with CDK2 phospho (Thr160) (verified), CDK3 phospho (Thr172) (verified), and CDK7 phospho (Thr170) (expected, not verified) due to the high homology/identity with CDK1 phospho (Thr161) site.

HRP Anti-CDK1 antibody [EPR165], Abcam, AB305703

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-CDK1 antibody [EPR165], Abcam, AB305701

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-CDK1 antibody [YE324], Abcam, AB319424

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

CDK1 / CDK2 / CDK3 (pT14) Antibody, Abbexa, abx329906

CDK1/CDK2/CDK3 (pT14) Antibody is a Rabbit Polyclonal against CDK1/CDK2/CDK3 (pT14).

Phospho-Cdk1/2 (Thr14) Antibody, Covalab, Ref 00120755

CDK1/2 Rabbit PolymAb®, ABclonal, A26696PM